Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein
Clinical trial NCT03462004 · TERMINATED
Trial details
- NCT number
- NCT03462004
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2019-03-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.